美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · PODD近 30 天 10 則 · 第 1 / 1 頁
- BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status
- Beta Bionics’ insulin patch pump gets FDA nod
- Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
- Artisan Sold Insulet (PODD) Due to Competition Concerns
- Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
- Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks
- MiniMed submits new patch pump for FDA clearance
- Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution
- Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players
- Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?
- 5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call
- These Two Medical Stocks Are Screaming Sell — Here's What Happened
- Beta Bionics to launch its first insulin patch pump to compete with Insulet
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。